S&P 500

5.303,17

-0,07%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

CORV

Correvio Pharma (CORV)

Correvio Pharma Corporation

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CORV

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
09/06/2020	12h02	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:CORV	Correvio Pharma Corporation
28/05/2020	12h00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CORV	Correvio Pharma Corporation
28/05/2020	12h00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	22h24	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	19h01	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	12h06	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 193...	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	12h03	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	12h03	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	12h02	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	12h01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CORV	Correvio Pharma Corporation
26/05/2020	23h30	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CORV	Correvio Pharma Corporation
21/05/2020	22h50	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CORV	Correvio Pharma Corporation
21/05/2020	22h01	PR Newswire (US)	Correvio Obtains Final Order for Plan of Arrangement	NASDAQ:CORV	Correvio Pharma Corporation
21/05/2020	22h01	PR Newswire (Canada)	Correvio Obtains Final Order for Plan of Arrangement	NASDAQ:CORV	Correvio Pharma Corporation
18/05/2020	12h03	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CORV	Correvio Pharma Corporation
15/05/2020	23h55	PR Newswire (Canada)	Correvio Announces Results from Annual General and Special Meeting of Securityholders	NASDAQ:CORV	Correvio Pharma Corporation
15/05/2020	23h55	PR Newswire (US)	Correvio Announces Results from Annual General and Special Meeting of Securityholders	NASDAQ:CORV	Correvio Pharma Corporation
06/05/2020	19h02	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CORV	Correvio Pharma Corporation
06/05/2020	14h00	PR Newswire (US)	Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVAN...	NASDAQ:CORV	Correvio Pharma Corporation
06/05/2020	14h00	PR Newswire (Canada)	Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVAN...	NASDAQ:CORV	Correvio Pharma Corporation
04/05/2020	18h46	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CORV	Correvio Pharma Corporation
04/05/2020	14h00	PR Newswire (US)	Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19	NASDAQ:CORV	Correvio Pharma Corporation
04/05/2020	14h00	PR Newswire (Canada)	Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19	NASDAQ:CORV	Correvio Pharma Corporation
01/05/2020	19h32	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CORV	Correvio Pharma Corporation
01/05/2020	14h00	PR Newswire (US)	Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA	NASDAQ:CORV	Correvio Pharma Corporation
01/05/2020	14h00	PR Newswire (Canada)	Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA	NASDAQ:CORV	Correvio Pharma Corporation
30/04/2020	12h23	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:CORV	Correvio Pharma Corporation
21/04/2020	03h56	PR Newswire (US)	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Are Shareholders Getting a Fair Deal?	NASDAQ:CORV	Correvio Pharma Corporation
17/04/2020	23h08	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CORV	Correvio Pharma Corporation
16/04/2020	23h30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CORV	Correvio Pharma Corporation